Wells Fargo & Company upgraded shares of Molina Healthcare (NYSE:MOH - Free Report) from an equal weight rating to an overweight rating in a report issued on Wednesday morning, Marketbeat.com reports. They currently have $372.00 price objective on the stock, up from their previous price objective of $295.00.
Other equities research analysts have also recently issued research reports about the stock. UBS Group decreased their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Stephens reaffirmed an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Truist Financial decreased their price target on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. Mizuho cut their price objective on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Barclays dropped their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research report on Friday, February 7th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $355.69.
Check Out Our Latest Report on MOH
Molina Healthcare Price Performance
MOH stock traded up $3.28 during mid-day trading on Wednesday, hitting $327.11. The company had a trading volume of 1,060,986 shares, compared to its average volume of 773,847. The company has a market capitalization of $18.15 billion, a price-to-earnings ratio of 16.01, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare has a 12-month low of $262.32 and a 12-month high of $423.92. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $295.28 and a 200 day moving average price of $311.91.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, research analysts anticipate that Molina Healthcare will post 24.4 earnings per share for the current year.
Insider Transactions at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.10% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its holdings in Molina Healthcare by 7.4% in the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares during the period. State Street Corp raised its stake in shares of Molina Healthcare by 0.5% during the third quarter. State Street Corp now owns 2,614,311 shares of the company's stock valued at $900,787,000 after purchasing an additional 13,001 shares during the period. FMR LLC raised its stake in shares of Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the period. Geode Capital Management LLC increased its stake in shares of Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after buying an additional 34,992 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of Molina Healthcare by 28.5% in the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after buying an additional 294,180 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.